Journal List > Perinatology > v.29(2) > 1098803

Jo, Jung, Lee, Kim, Choi, Joo, Choi, Jang, Hwang, and Choi: Amniotic Fluid Embolism: Maternal Disseminated Intravascular Coagulation, Cardiovascular Collapse, and Acute Hypoxic Cases Shortly after Delivery

Abstract

Amniotic fluid embolism (AFE) is a fatal disease in only pregnant woman during labor and delivery. The pathologic findings that have demonstrated fetal squamous cells in the pulmonary circulation are no more specific. Then, clinically characteristic signs and symptoms, such as cardiovascular collapse, acute hypoxia, disseminated intravascular coagulation, mental change and laboratory findings are the key points for diagnosis. Having a doubt on those sign and symptoms is the beginning of diagnosis and promptly multidisciplinary management is required. Korean National Registry for AFE must be established and we have to find out the diagnostic criteria, possible etiology, pathophysiology, management and treatment for AFE.

REFERENCES

1). Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@ smfm.org, Pacheco LD, Saade G, Hankins GD, Clark SL. Amniotic fluid embolism: diagnosis and management. Am J Obstet Gynecol. 2016. 215:B16–24.
2). Shamshirsaz AA., Clark SL. Amniotic fluid embolism. Obstet Gynecol Clin North Am. 2016. 43:779–90.
crossref
3). Meyer JR. Embolia pulmonary amnio caseosa. J Bras Med. 1926. 2:301–3.
4). Steiner PE., Lushbaugh CC. Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA. 1941. 117:1245–54.
5). Liban E., Raz S. A clinicopathologic study of fourteen cases of amniotic fluid embolism. Am J Clin Pathol. 1969. 51:477–86.
crossref
6). Steiner PE., Lushbaugh CC. Landmark article, Oct. 1941: Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. By Paul E. Steiner and C. C. Lushbaugh. JAMA. 1986. 255:2187–203.
7). Clark SL. New concepts of amniotic fluid embolism: a review. Obstet Gynecol Surv. 1990. 45:360–8.
8). Belfort M., Saade G., Foley M., Phelan J., Dildy G. Critical care obstetrics. 5th ed. Oxford: Wiley-Blackwell, 2010, p. 466–74.
9). Clark SL., Paylova Z., Greenspoon J., Horenstein J., Phelan JP. Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol. 1986. 154:104–6.
crossref
10). Lau G. Amniotic fluid embolism as a cause of sudden maternal death. Med Sci Law. 1994. 34:213–20.
crossref
11). Benson MD. Amniotic fluid embolism: the known and not known. Obstet Med. 2014. 7:17–21.
crossref
12). Romero R., Kadar N., Vaisbuch E., Hassan SS. Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection? Am J Reprod Immunol. 2010. 64:113–25.
crossref
13). Conde-Agudelo A., Romero R. Amniotic fluid embolism: an evidence-based review. Am J Obstet Gynecol. 2009. 201:445. .e1-13.
crossref
14). Benson MD. A hypothesis regarding complement activation and amniotic fluid embolism. Med Hypotheses. 2007. 68:1019–25.
crossref
15). James CF., Feinglass NG., Menke DM., Grinton SF., Papadimos TJ. Massive amniotic fluid embolism: diagnosis aided by emergency transesophageal echocardiography. Int J Obstet Anesth. 2004. 13:279–83.
crossref
16). Clark SL., Hankins GD., Dudley DA., Dildy GA., Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol. 1995. 172:1158–67.
crossref
17). Kim BI., Paek SH., Rho WS., Lee SP., Cho SK., Lee SH. Amniotic fluid embolism during dilatation and curettage in a second trimesteric missed aborted pregnant patient. Korean J Anesthesiol. 1997. 33:778–83.
crossref
18). Clark SL., Romero R., Dildy GA., Callaghan WM., Smiley RM., Bracey AW, et al. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2016. 215:408–12.
crossref
19). Tanaka H., Katsuragi S., Osato K., Hasegawa J., Nakata M., Murakoshi T, et al. Value of fibrinogen in cases of maternal death related to amniotic fluid embolism. J Matern Fetal Neonatal Med. 2017. 30:2940–3.
crossref
20). Rath WH., Hofer S., Sinicina I. Amniotic fluid embolism: an interdisciplinary challenge: epidemiology, diagnosis and treatment. Dtsch Arztebl Int. 2014. 111:126–32.
21). Matsuda Y., Kamitomo M. Amniotic fluid embolism: a comparison between patients who survived and those who died. J Int Med Res. 2009. 37:1515–21.
crossref
22). Leighton BL., Wall MH., Lockhart EM., Phillips LE., Zatta AJ. Use of recombinant factor VIIa in patients with amniotic fluid embolism: a systematic review of case reports. Anesthesiology. 2011. 115:1201–8.
23). Clark SL. Successful pregnancy outcomes after amniotic fluid embolism. Am J Obstet Gynecol. 1992. 167:511–2.
crossref
24). Stiller RJ., Siddiqui D., Laifer SA., Tiakowski RL., Whetham JC. Successful pregnancy after suspected anaphylactoid syndrome of pregnancy (amniotic fluid embolus). A case report. J Reprod Med. 2000. 45:1007–9.
25). Kim JI., Kim TH., Park KG. A case of amniotic fluid embolism: detection by postmortem autopsy. Korean J Perinatol. 1994. 5:363–67.
26). Kim JY., Yang JI., Ryu HS., Oh KS., Joo HJ. A case of amniotic fluid embolism in cervical vessels after delivery. Korean J Obstet Gynecol. 1997. 40:1528–31.
27). Park CW., Kim SS., Han SY., Ko EM., Shim SS., Cheon DW, et al. A case of amniotic fluid embolism during the labor. Korean J Obstet Gynecol. 2002. 45:864–8.
28). Kim SY., Kang BS., Park CM. A case of intrapartum amniotic fluid embolism with seizure. Korean J Obstet Gynecol. 2006. 49:2199–203.
29). Lee JH., Yang HJ., Kim JH., Lee SY., Gill HJ., Kim BK, et al. Amniotic fluid embolism that took place during an emergent cesarean section -A case report-. Korean J Anesthesiol. 2010. 59(Suppl):S158–62.
crossref
30). Stolk KH., Zwart JJ., Schutte J., Roosmalen JV. Severe maternal morbidity and mortality from amniotic fluid embolism in the Netherlands. Acta Obstet Gynecol Scand. 2012. 91:991–5.
crossref

Table 1.
Clinical Characteristics of AFE Cases That Have Been Reported in Korea
  125 226 317 427 528 629
Presented at 1994, Perinatology 1997, KJOG 1997, KJA 2002, KJOG 2006, KJOG 2010, KJA
Method of diagnosis Autopsy Histopathological test at uterine cervical vessel Clinical symptoms, blood test Clinical symptoms Clinical symptoms Clinical symptoms, autopsy
Age (year) 34 27 30 42 36 33
Gravida Primigravida Multigravida Multigravida Primigravida Multigravida Primigravida
GA (weeks) 40 38 15+2 40+6 39+3 40
IOL Yes - - Yes, oxytocin Yes, oxytocin Yes, oxytocin
Delivery method Vaginal Vaginal Dilatation & curettage Did not delivery Vaginal Cesarean section
Time of initiation 2 hours after delivery Just after delivery 28 minutes after procedure Simultaneous with fetal distress Simultaneous with fetal distress 5 minutes after spinal anesthesia
Initial sign and symptoms Postpartum bleeding, irritability, semicoma Postpartum bleeding, shock Cyanosis, hypotension Fetal distress, maternal cyanosis, hypotension Fetal distress, seizure, loss of consciousness Maternal respiratory distress, coughing, hypotension
Clinical sign and symptoms Postpartum bleeding, irritability, semicoma, hypotension Postpartum atony bleeding Cyanosis, hypotension, loss of cons Respiratory arrest, cardiac arrest ciousness, DIC Fetal distress, coma, hypotension Respiratory distress, hypotension, profuse tracheal discharge
Prognosis Death within 6 hours after delivery Improved Hypoxic brain damage, motor disability Death within 2 hours after initial symptoms Death within 5 hours after initial symptoms Death within 3 hours after initial symptoms

Abbreviations: AFE, Amniotic Fluid Embolism; KJOG, Korean J Obstet Gynecol; KJA, Korean J Anesthesiology; GA, gestaional age; IOL, induction of labor; DIC, disseminated intravascular coagulation.

Confirm fetal origin squamous cells at maternal pulmonary vessel.

Blood tests for DIC.

Table 2.
Suggested Diagnostic Criterias for AFE
Diagnostic sign & symptoms UK18 Australia18 Netherlands30 Japan18 USA18
Clinical sign and symptoms          
Acute hypotension + + + + Systolic <90 mmHg)
Cardiac arrest + + + + +
Acute hypoxia + + + + SpO2 <90%
DIC + + + + +
Coma, seizure     +    
Heavy bleeding ≥ 1,500 mL, within 2 hours after delivery
Body temperature         <38°C
Time of initiation     Within 48 hours after delivery During pregnancy, or labor, and within 12 hours after delivery Within labor, or 30 minutes after placenta delivery
Histopathological test (fetal origin squamous cells at maternal pulmonary vessels) + +   +, and at uterine artery  
Needs to differentiate other disease + + + + +

Abbreviations: AFE, amniotic fluid embolism; DIC, disseminated intravascular coagulation.

Table 3.
Suggestion of Diagnostic Criteria of AFE
Time of initiation During labor, delivery, and cesarean section. At least within 2 hours after delivery. Do not over 24 hours after delivery.
Clinical sign and symptoms Acute hypotension, cardiac arrest, acute hypoxia, DIC, Loss of consciousness, seizure, heavy bleeding.
Differential diagnosis Pulmonary thromboembolism, transfusion complications, ischemic heart disease, anaphylactic shock, septic shock, perinatal cardiomyopathy, air embolism, high level spinal anesthesia, uterine rupture, uterine atony, reproductive tract laceration, postpartum heavy bleeding, acute fatty liver, severe preeclampsia, eclampsia, medical problems of heart, lung, and hematologic parts.
  Do not include histopathological test for fetal origin squamous cells at pulmonary and uterine vessels.

Abbreviations: AFE, Amniotic Fluid Embolism; DIC, disseminated intravascular coagulation.

Diagnostic criterias for hypotension, hypoxia, DIC must be suggested in the future.

TOOLS
Similar articles